Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.
Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien VR, Banissi C, Carpentier A, Sandoval F, Nizard M, Quintin-Colonna F, Kroemer G, Fridman WH, Zitvogel L, Oudard SP, Tartour E.
Pere H, et al.
Oncoimmunology. 2012 May 1;1(3):326-333. doi: 10.4161/onci.18852.
Oncoimmunology. 2012.
PMID: 22737608
Free PMC article.